These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 331469

  • 1. [Activation of the complement system in different forms of glomerulonephritis].
    Wegmüller E, Frey B, Hodler J.
    Schweiz Med Wochenschr; 1977 Jul 23; 107(29):1028-34. PubMed ID: 331469
    [Abstract] [Full Text] [Related]

  • 2. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH, Lambert PH, Miescher PA.
    J Clin Invest; 1975 Jul 23; 56(1):165-76. PubMed ID: 1141431
    [Abstract] [Full Text] [Related]

  • 3. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov 23; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 4. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I, Seino J, Sudo K, Kinoshita Y, Saito T, Yoshinaga K.
    Clin Exp Immunol; 1987 Nov 23; 70(2):417-24. PubMed ID: 3427827
    [Abstract] [Full Text] [Related]

  • 5. [The complement system].
    Lambert PH.
    Schweiz Med Wochenschr; 1975 Sep 13; 105(37):1180-4. PubMed ID: 1215899
    [Abstract] [Full Text] [Related]

  • 6. Complement deposition in glomerular diseases.
    di Belgiojoso GB, Tarantino A, Durante A, Guerra L.
    Proc Eur Dial Transplant Assoc; 1975 Sep 13; 11():515-21. PubMed ID: 1105561
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP, Morel-Maroger L, Boelaert J.
    Proc Eur Dial Transplant Assoc; 1975 Sep 13; 11():506-11. PubMed ID: 1197274
    [No Abstract] [Full Text] [Related]

  • 8. Serum and glomerular complement in 205 cases of glomerulonephritis.
    Durante A, Rovati C, di Belgiojoso GB, Minetti L.
    Proc Eur Dial Transplant Assoc; 1976 Sep 13; 12():189-96. PubMed ID: 935112
    [Abstract] [Full Text] [Related]

  • 9. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov 13; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 10. Activation of complement in human nephritis.
    Lambert PH, Perrin LH, Mahieu P, Nydegger UE, Miescher PA.
    Adv Nephrol Necker Hosp; 1974 Nov 13; 4():79-90. PubMed ID: 4220001
    [No Abstract] [Full Text] [Related]

  • 11. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB, Tarantino A, Bazzi C, Colasanti G, Guerra L, Durante A.
    Clin Nephrol; 1976 Jul 13; 6(1):303-10. PubMed ID: 782750
    [Abstract] [Full Text] [Related]

  • 12. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR, Forristal J, Beischel L.
    J Lab Clin Med; 1986 Jun 13; 107(6):529-33. PubMed ID: 3635565
    [Abstract] [Full Text] [Related]

  • 13. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC, Freyria AM.
    Nephrologie; 1980 Jun 13; 1(2):61-6. PubMed ID: 7301022
    [Abstract] [Full Text] [Related]

  • 14. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H, Good RA, Day NK.
    Clin Nephrol; 1975 Jun 13; 3(4):139-47. PubMed ID: 1149337
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K, Ward D, Ruddy S.
    Clin Exp Immunol; 1979 Jan 13; 35(1):101-6. PubMed ID: 85507
    [Abstract] [Full Text] [Related]

  • 16. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.
    Perrin LH, Lambert PH, Miescher PA.
    Clin Exp Immunol; 1974 Apr 13; 16(4):575-81. PubMed ID: 4219766
    [Abstract] [Full Text] [Related]

  • 17. Evidence for activation of the alternate pathway in glomerulonephritis.
    Michael AF, McLean RH.
    Adv Nephrol Necker Hosp; 1974 Apr 13; 4():49-66. PubMed ID: 4219999
    [No Abstract] [Full Text] [Related]

  • 18. Studies of serum complement in the hypocomplementaemic nephritides.
    Williams DG, Peters DK, Fallows J, Petrie A, Kourilsky O, Morel-Maroger L, Cameron JS.
    Clin Exp Immunol; 1974 Nov 13; 18(3):391-405. PubMed ID: 4219908
    [Abstract] [Full Text] [Related]

  • 19. The biological role of the complement system and the clinical importance of complement measurements.
    Füst G.
    Haematologia (Budap); 1974 Nov 13; 12(1-4):85-106. PubMed ID: 395046
    [Abstract] [Full Text] [Related]

  • 20. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM, Vallota EH, West CD.
    Kidney Int; 1976 Jan 13; 9(1):46-53. PubMed ID: 781380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.